MRNA
Income statement / Annual
Last year (2023), Moderna, Inc.'s total revenue was $6.85 B,
a decrease of 64.45% from the previous year.
In 2023, Moderna, Inc.'s net income was -$4.71 B.
See Moderna, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
Operating Revenue |
$6.85 B |
$19.26 B |
$17.74 B |
$274.49 M |
$48.04 M |
$122.51 M |
$176.97 M |
$101.54 M |
Cost of Revenue |
$4.69 B
|
$5.42 B
|
$2.62 B
|
$7.93 M
|
$31.02 M
|
$454.08 M
|
$20.54 M
|
$15.11 M
|
Gross Profit |
$2.16 B
|
$13.85 B
|
$15.12 B
|
$266.56 M
|
$17.02 M
|
-$331.57 M
|
$156.44 M
|
$86.42 M
|
Gross Profit Ratio |
0.31
|
0.72
|
0.85
|
0.97
|
0.35
|
-2.71
|
0.88
|
0.85
|
Research and Development Expenses |
$4.85 B
|
$3.30 B
|
$1.99 B
|
$1.37 B
|
$496.31 M
|
$454.08 M
|
$410.46 M
|
$274.72 M
|
General & Administrative Expenses |
$1.35 B
|
$1.01 B
|
$0.00
|
$0.00
|
$109.62 M
|
$94.25 M
|
$64.72 M
|
$57.45 M
|
Selling & Marketing Expenses |
$204.00 M
|
$121.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$1.55 B
|
$1.13 B
|
$567.00 M
|
$188.27 M
|
$109.62 M
|
$94.25 M
|
$64.72 M
|
$57.45 M
|
Other Expenses |
-$94.00 M
|
-$45.00 M
|
-$735.00 M
|
-$528.91 M
|
$0.00
|
-$12.56 M
|
-$28.85 M
|
-$2.71 M
|
Operating Expenses |
$6.30 B
|
$4.43 B
|
$1.82 B
|
$1.03 B
|
$593.76 M
|
$535.78 M
|
$446.33 M
|
$325.31 M
|
Cost And Expenses |
$11.09 B
|
$9.84 B
|
$4.44 B
|
$1.04 B
|
$593.76 M
|
$535.78 M
|
$446.33 M
|
$325.31 M
|
Interest Income |
$421.00 M
|
$200.00 M
|
$18.00 M
|
$24.72 M
|
$38.53 M
|
$27.02 M
|
$15.24 M
|
$11.31 M
|
Interest Expense |
$38.00 M
|
$29.00 M
|
$18.00 M
|
$9.89 M
|
$6.61 M
|
$3.10 M
|
$132,000.00
|
$0.00
|
Depreciation & Amortization |
$621.00 M
|
$348.00 M
|
$232.00 M
|
$31.25 M
|
$31.02 M
|
$24.86 M
|
$20.54 M
|
$15.11 M
|
EBITDA |
-$3.28 B |
$9.77 B |
$13.53 B |
-$732.00 M |
-$515.00 M |
-$388.40 M |
-$235.33 M |
-$208.66 M |
EBITDA Ratio |
-0.48
|
0.51
|
0.75
|
-2.78
|
-11.36
|
-3.37
|
-1.41
|
-2.06
|
Operating Income Ratio |
-0.62
|
0.49
|
0.75
|
-2.78
|
-11.36
|
-3.37
|
-1.52
|
-2.2
|
Total Other Income/Expenses Net |
$297.00 M
|
$155.00 M
|
-$11.00 M
|
$18.63 M
|
$31.00 M
|
$28.86 M
|
$13.36 M
|
$8.60 M
|
Income Before Tax |
-$3.94 B
|
$9.58 B
|
$13.29 B
|
-$744.51 M
|
-$514.72 M
|
-$384.41 M
|
-$256.00 M
|
-$215.17 M
|
Income Before Tax Ratio |
-0.58
|
0.5
|
0.75
|
-2.71
|
-10.72
|
-3.14
|
-1.45
|
-2.12
|
Income Tax Expense |
$772.00 M
|
$1.21 B
|
$1.08 B
|
$2.55 M
|
-$695,000.00
|
$326,000.00
|
-$80,000.00
|
$1.04 M
|
Net Income |
-$4.71 B
|
$8.36 B
|
$12.20 B
|
-$747.06 M
|
-$514.02 M
|
-$384.73 M
|
-$255.92 M
|
-$216.21 M
|
Net Income Ratio |
-0.69
|
0.43
|
0.69
|
-2.72
|
-10.7
|
-3.14
|
-1.45
|
-2.13
|
EPS |
-12.34 |
21.22 |
30.28 |
-1.96 |
-1.55 |
-4.74 |
-0.68 |
-0.58 |
EPS Diluted |
-12.34 |
20.1 |
28.31 |
-1.96 |
-1.55 |
-4.74 |
-0.68 |
-0.58 |
Weighted Average Shares Out |
$382.00 M
|
$394.00 M
|
$403.00 M
|
$381.33 M
|
$330.80 M
|
$81.11 M
|
$376.00 M
|
$376.00 M
|
Weighted Average Shares Out Diluted |
$382.00 M
|
$416.00 M
|
$431.00 M
|
$381.33 M
|
$330.80 M
|
$81.11 M
|
$376.00 M
|
$376.00 M
|
Link |
|
|
|
|
|
|
|
|